alpha-aminopyridine has been researched along with Metaplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, IC; Lu, YS; Yang, MH | 1 |
| Cortijo, J; Martinez, I; Mata, M; Melero, JA; Tenor, H | 1 |
2 other study(ies) available for alpha-aminopyridine and Metaplasia
| Article | Year |
|---|---|
PI3K inhibitor provides durable response in metastatic metaplastic carcinoma of the breast: A hidden gem in the BELLE-4 study.
Topics: Aged, 80 and over; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Female; Humans; Metaplasia; Morpholines; Paclitaxel; Phosphoinositide-3 Kinase Inhibitors; Randomized Controlled Trials as Topic; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Roflumilast inhibits respiratory syncytial virus infection in human differentiated bronchial epithelial cells.
Topics: Aminopyridines; Antioxidants; Axonemal Dyneins; Benzamides; Biomarkers; Bronchi; Cell Count; Cell Differentiation; Chloride Channels; Cilia; Cyclopropanes; Cytokines; Epithelial Cells; Forkhead Transcription Factors; Goblet Cells; Humans; Metaplasia; Mucin 5AC; Oxidative Stress; Reactive Oxygen Species; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; RNA, Messenger; Tubulin; Viral Load; Virus Replication | 2013 |